ANAVEX-1037

N/A

Report date: 2025/06/11 10:36:05
NME

Base Information

Drug NameANAVEX-1037
Drug Alias Namesigma-1 and sigma-2 receptor ligand/muscarinic M3 receptor antagonist (Anavex)ANAVEX-1007ANAVEX-1037
ClassificationSmall molecules
Mechanisms of ActionMuscarinic acetylcholine receptor M3 antagonistsSigma-2 receptor modulatorsMetastasis inhibitors +[5] 
TargetsSigma-2 receptorSodium channelsMuscarinic acetylcholine receptor M3
Therapy Area/IndicationsNeuralgiaProstatic NeoplasmsColonic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAnavex Life Sciences Corp
China Registration ClassN/A

Develop Information

Active CompaniesAnavex Life Sciences Corp
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsNeuralgiaColonic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A